Questionable levels of evidence in new atrial fibrillation guidelines?

Europace

Volumn 15, Issue 3, 2013, Pages 461-

  Van Brabandt, Hans ^a   Neyt, Mattias ^a   Devos, Carl ^a  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIOVASCULAR MORTALITY; CATHETER ABLATION; COST; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; LETTER; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT DURATION; FEMALE; MALE; NOTE;

ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE;

EID: 84874438243     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus393     Document Type: Letter

References (13)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace 2012;14:1385-413.
2. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2:349-61.
3. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010; 303:333-40.
4. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure. Europace 2012;14:818-25.
5. Van Brabandt H, Neyt M, Devos C. Catheter Ablation of Atrial Fibrillation (HTA). Brussels: Belgian Health Care Knowledge Centre; 2012 September 26, 2012. Report No.: 184C.
6. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
7. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012; 59:143-9.
8. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation. Europace 2010;12: 1360-420.
9. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21.
10. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: A systematic review. Am J Med 2006;119:448 e441-419.
11. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
12. Osterweil. MANTRA-PAF: RF ablation superior to drugs in paroxysmal AF. MedwireNews, 2011.
13. Neale. Ablation could be first-line Afib therapy. MedPage Today, 2011.